Evidence map›Paper›PMID 8947928›Full record

ReviewNeurochemical research1996

Effects of opioids on the immune system.

S Roy, H H Loh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 192 citations in OpenAlex.

  1. Guideline
  2. Pharmacokinetics of transdermal buprenorphine patch in the elderly.European journal of clinical pharmacology · 2013
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Narcotic analgesics.Inflammopharmacology · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. A double-edged sword of using opioids and COVID-19: a toxicological view.Substance abuse treatment, prevention, and policy · 2020
    Article
  20. NSAIDs for analgesia in the era of COVID-19.Regional anesthesia and pain medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S RoyDepartment of Pharmacology, University of Minnesota, Minneapolis, 55455, USA.
H H Loh
University of Minnesota · US

Funding

Structural and Functions Studies of Mu Opiate Receptors: Regulation of its GeneR01DA001583 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2017
$6.5M
NEUROCHEMICAL BASIS ON NARCOTIC ADDICTIONR01DA000564 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2010
$5.1M
Neurochemical Basis of Opiate AddictionR56DA000564 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE, LOH, HORACE · 2012 to 2013
$329k
REGULATION OF NEUROPEPTIDES &RECEP FUNCP01DA005695 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE H · 1989 to 1999
–
STRUCTURAL AND FUNCTIONAL STUDIES OF MU OPIOID RECEPTORSR37DA001583 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE H · 1987 to 1996
–
NIDA NIH HHS DA 00564NIDA NIH HHS DA 01583NIDA NIH HHS DA 05695
6 · The paper itself

Abstract

Both therapeutic and chronic uses of opioids compromise the optimal functioning of the immune system. Overwhelming evidence suggests that opioid use affects both innate immunity and adaptive immunity. Chronic administration of opioids decreases the proliferative capacity of macrophage progenitor cells and lymphocytes. Additionally, the differentiated function of immune cells is significantly affected by opioids. These effects are mediated by either a direct action of opioids on the target cells or by indirect centrally mediated pathways. Molecular biological and biochemical characterization suggest that immune cells differentially express classical opioid receptors. Interestingly, these studies also reveal the presence of a novel class of opioid receptors in immune cells. We believe that this low affinity morphine binding site mediates the antiproliferative effects of morphine.

Indexed as

AnimalsB-LymphocytesBone MarrowHematopoietic Stem CellsHumansImmune SystemKiller Cells, NaturalMorphineNarcoticsReceptors, OpioidT-LymphocytesMorphineNarcoticsReceptors, Opioid

Identifiers

PMID8947928
OpenAlexW2039470219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.